Statins and antimicrobial effects: Simvastatin as a potential drug against Staphylococcus aureus biofilm

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Graziano, Talita Signoreti ^a   Cuzzullin, Maria Claudia ^a   Franco, Gilson Cesar ^b   Schwartz Filho, Humberto Osvaldo ^c   De Andrade, Eduardo Dias ^a   Groppo, Francisco Carlos ^a   Cogo Müller, Karina ^a,c  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b STATE UNIVERSITY OF PONTA GROSSA   (Brazil)

^c UNIVERSITY OF SANTO AMARO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; PRAVASTATIN; SIMVASTATIN; ANTIINFECTIVE AGENT; HYPOCHOLESTEROLEMIC AGENT; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIABILITY; BACTERIUM ADHERENCE; BIOFILM; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; LINEZOLID RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; DRUG EFFECTS; DRUG REPOSITIONING; GROWTH, DEVELOPMENT AND AGING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY;

ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; ANTICHOLESTEREMIC AGENTS; ATORVASTATIN CALCIUM; BACTERIAL ADHESION; BIOFILMS; DRUG REPOSITIONING; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; PRAVASTATIN; PSEUDOMONAS AERUGINOSA; SIMVASTATIN; VANCOMYCIN;

EID: 84933055578     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128098     Document Type: Article

References (49)

1. Smith SC Jr, Grundy SM. 2013 ACC/AHA guideline recommends fixed-dose strategies instead of targeted goals to lower blood cholesterol. Journal of the American College of Cardiology. 2014; 64 (6):601-12. doi: 10.1016/j.jacc.2014.06.1159 PubMed PMID: PMID: 25104531.
2. Alla VM, Agrawal V, DeNazareth A, Mohiuddin S, Ravilla S, Rendell M. A reappraisal of the risks and benefits of treating to target with cholesterol lowering drugs. Drugs. 2013; 73(10):1025-54. doi: 10.1007/s40265-013-0072-9 PubMed PMID: PMID: 23754124.
3. Wilt TJ, Bloomfield HE, MacDonald R, Nelson D, Rutks I, Ho M, et al. Effectiveness of statin therapy in adults with coronary heart disease. Archives of internal medicine. 2004; 164(13):1427-36. doi: 10.1001/archinte.164.13.1427 PubMed PMID: PMID: 15249352.
4. McTaggart F, Buckett L, Davidson R, Holdgate G, McCormick A, Schneck D, et al. Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. The American journal of cardiology. 2001; 87(5A):28B-32B. PubMed PMID: PMID: 11256847.
5. Shitara Y, Sugiyama Y. Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions. Pharmacology & therapeutics. 2006; 112(1):71-105. doi: 10.1016/j.pharmthera.2006.03.003 PubMed PMID: PMID: 16714062.
6. Liao JK, Laufs U. Pleiotropic effects of statins. Annual review of pharmacology and toxicology. 2005; 45:89-118. doi: 10.1146/annurev.pharmtox.45.120403.095748 PubMed PMID: PMID: 15822172; PubMed Central PMCID: PMC2694580.
7. Lefer DJ. Statins as potent antiinflammatory drugs. Circulation. 2002; 106(16):2041-2. PubMed PMID: PMID: 12379569.
8. Bonetti PO, Lerman LO, Napoli C, Lerman A. Statin effects beyond lipid lowering-are they clinically relevant? European heart journal. 2003; 24(3):225-48. PubMed PMID: PMID: 12590901.
9. Almog Y, Shefer A, Novack V, Maimon N, Barski L, Eizinger M, et al. Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation. 2004; 110(7):880-5. doi: 10.1161/01.CIR.0000138932.17956.F1 PubMed PMID: PMID: 15289367.
10. Bjorkhem-Bergman L, Bergman P, Andersson J, Lindh JD. Statin treatment and mortality in bacterial infections - a systematic review and meta-analysis. PloS one. 2010; 5(5):e10702. doi: 10.1371/journal.pone.0010702 PubMed PMID: PMID: 20502712; PubMed Central PMCID: PMC2873291.
11. Khan AR, Riaz M, Bin Abdulhak AA, Al-Tannir MA, Garbati MA, Erwin PJ, et al. The role of statins in prevention and treatment of community acquired pneumonia: a systematic review and meta-analysis. PloS one. 2013; 8(1):e52929. doi: 10.1371/journal.pone.0052929 PubMed PMID: PMID: 23349694; PubMed Central PMCID: PMC3538683.
12. Thomsen RW, Hundborg HH, Johnsen SP, Pedersen L, Sorensen HT, Schonheyder HC, et al. Statin use and mortality within 180 days after bacteremia: a population-based cohort study. Critical care medicine. 2006; 34(4):1080-6. doi: 10.1097/01.CCM.0000207345.92928.E4 PubMed PMID: PMID: 16484926.
13. Janda S, Young A, Fitzgerald JM, Etminan M, Swiston J. The effect of statins on mortality from severe infections and sepsis: a systematic review and meta-analysis. Journal of critical care. 2010; 25(4):656 e7-22. doi: 10.1016/j.jcrc.2010.02.013 PubMed PMID: PMID: 20413251.
14. Wan YD, Sun TW, Kan QC, Guan FX, Zhang SG. Effect of statin therapy on mortality from infection and sepsis: a meta-analysis of randomized and observational studies. Critical care. 2014; 18(2):R71. doi: 10.1186/cc13828 PubMed PMID: PMID: 24725598; PubMed Central PMCID: PMC4056771.
15. van den Hoek HL, Bos WJ, de Boer A, van de Garde EM. Statins and prevention of infections: systematic review and meta-analysis of data from large randomised placebo controlled trials. Bmj. 2011; 343: d7281. doi: 10.1136/bmj.d7281 PubMed PMID: PMID: 22127443; PubMed Central PMCID: PMC3226140.
16. Lopez-Cortes LE, Galvez-Acebal J, Del Toro MD, Velasco C, de Cueto M, Caballero FJ, et al. Effect of statin therapy in the outcome of bloodstream infections due to Staphylococcus aureus: a prospective cohort study. PloS one. 2013; 8(12):e82958. doi: 10.1371/journal.pone.0082958 PubMed PMID: PMID: 24376617; PubMed Central PMCID: PMC3871563.
17. Horn MP, Knecht SM, Rushing FL, Birdsong J, Siddall CP, Johnson CM, et al. Simvastatin inhibits Staphylococcus aureus host cell invasion through modulation of isoprenoid intermediates. The Journal of pharmacology and experimental therapeutics. 2008; 326(1):135-43. doi: 10.1124/jpet.108.137927 PubMed PMID: PMID: 18388257.
18. Bergman P, Linde C, Putsep K, Pohanka A, Normark S, Henriques-Normark B, et al. Studies on the antibacterial effects of statins-in vitro and in vivo. PloS one. 2011; 6(8):e24394. doi: 10.1371/journal.pone.0024394 PubMed PMID: PMID: 21912631; PubMed Central PMCID: PMC3166163.
19. Jerwood S, Cohen J. Unexpected antimicrobial effect of statins. The Journal of antimicrobial chemotherapy. 2008; 61(2):362-4. doi: 10.1093/jac/dkm496 PubMed PMID: PMID: 18086693.
20. Kozarov E, Padro T, Badimon L. View of statins as antimicrobials in cardiovascular risk modification. Cardiovascular research. 2014; 102(3):362-74. doi: 10.1093/cvr/cvu058 PubMed PMID: PMID: 24623278.
21. Welsh AM, Kruger P, Faoagali J. Antimicrobial action of atorvastatin and rosuvastatin. Pathology. 2009; 41(7):689-91. doi: 10.3109/00313020903305860 PubMed PMID: PMID: 20001351.
22. Masadeh M, Mhaidat N, Alzoubi K, Al-Azzam S, Alnasser Z. Antibacterial activity of statins: a comparative study of atorvastatin, simvastatin, and rosuvastatin. Annals of clinical microbiology and antimicrobials. 2012; 11:13. doi: 10.1186/1476-0711-11-13 PubMed PMID: PMID: 22564676; PubMed Central PMCID: PMC3408379.
23. Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America. 2013; 34(1):1-14. doi: 10.1086/668770 PubMed PMID: PMID: 23221186.
24. Gill SR, Fouts DE, Archer GL, Mongodin EF, Deboy RT, Ravel J, et al. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. Journal of bacteriology. 2005; 187(7):2426-38. doi: 10.1128/JB.187.7.2426-2438.2005 PubMed PMID: PMID: 15774886; PubMed Central PMCID: PMC1065214.
25. Hall-Stoodley L, Stoodley P. Biofilm formation and dispersal and the transmission of human pathogens. Trends in microbiology. 2005; 13(1):7-10. doi: 10.1016/j.tim.2004.11.004 PubMed PMID: PMID: 15639625.
26. Van Acker H, Van Dijck P, Coenye T. Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms. Trends in microbiology. 2014; 22(6):326-33. doi: 10.1016/j.tim.2014.02.001 PubMed PMID: PMID: 24598086.
27. CLSI. Clinical and Laboratory Standard Institute - Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, approved standard. Wayne, Pa, USA2006.
28. Raja AF, Ali F, Khan IA, Shawl AS, Arora DS, Shah BA, et al. Antistaphylococcal and biofilm inhibitory activities of acetyl-11-keto-beta-boswellic acid from Boswellia serrata. BMC microbiology. 2011; 11:54. doi: 10.1186/1471-2180-11-54 PubMed PMID: PMID: 21406118; PubMed Central PMCID: PMC3066120.
29. th Edition ed. Philadelphia, PA, USA: Lippincott Williams & Wilkins; 2005. p. 366-442.
30. th edition ed. Baltimore MD: Williams and Wilkins Co.; 1996.
31. Odds FC. Synergy, antagonism, and what the chequerboard puts between them. The Journal of antimicrobial chemotherapy. 2003; 52(1):1. doi: 10.1093/jac/dkg301 PubMed PMID: PMID: 12805255.
32. Sun L, Sun S, Cheng A, Wu X, Zhang Y, Lou H. In vitro activities of retigeric acid B alone and in combination with azole antifungal agents against Candida albicans. Antimicrobial agents and chemotherapy. 2009; 53(4):1586-91. doi: 10.1128/AAC.00940-08 PubMed PMID: PMID: 19171796; PubMed Central PMCID: PMC2663064.
33. Wu WS, Chen CC, Chuang YC, Su BA, Chiu YH, Hsu HJ, et al. Efficacy of combination oral antimicrobial agents against biofilm-embedded methicillin-resistant Staphylococcus aureus. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi. 2013; 46(2):89-95. doi: 10.1016/j.jmii.2012.03.009 PubMed PMID: PMID: 22572005.
34. Hawser SP, Douglas LJ. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infection and immunity. 1994; 62(3):915-21. PubMed PMID: PMID: 8112864; PubMed Central PMCID: PMC186203.
35. Aires CP, Del Bel Cury AA, Tenuta LM, Klein MI, Koo H, Duarte S, et al. Effect of starch and sucrose on dental biofilm formation and on root dentine demineralization. Caries research. 2008; 42(5):380-6. doi: 10.1159/000154783 PubMed PMID: PMID: 18781066.
36. DuBois M GK, Hamilton JK, Rebers PA, Smith F. Colorimetric Method for Determination of Sugars and Related Substances. Analytical Chemistry. 1956; 28(3):350-6.
37. Ccahuana-Vasquez RA, Cury JA. S. mutans biofilm model to evaluate antimicrobial substances and enamel demineralization. Brazilian oral research. 2010; 24(2):135-41. PubMed PMID: PMID: 20658029.
38. Hoffman WF, Alberts AW, Anderson PS, Chen JS, Smith RL, Willard AK. 3-Hydroxy-3-methylglutarylcoenzyme A reductase inhibitors. 4. Side chain ester derivatives of mevinolin. Journal of medicinal chemistry. 1986; 29(5):849-52. PubMed PMID: PMID: 3634830.
39. Mason RP, Walter MF, Day CA, Jacob RF. Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions. The American journal of cardiology. 2005; 96(5A):11F-23F. doi: 10.1016/j.amjcard.2005.06.008 PubMed PMID: PMID: 16126019.
40. Chamilos G, Lewis RE, Kontoyiannis DP. Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole. Antimicrobial agents and chemotherapy. 2006; 50(1):96-103. doi: 10.1128/AAC.50.1.96-103.2006 PubMed PMID: PMID: 16377673; PubMed Central PMCID: PMC1346800.
41. Galgoczy L, Papp T, Vagvolgyi C. In vitro interaction between suramin and fluvastatin against clinically important Zygomycetes. Mycoses. 2009; 52(5):447-53. doi: 10.1111/j.1439-0507.2008.01634.x PubMed PMID: PMID: 18983427.
42. Nyilasi I, Kocsube S, Krizsan K, Galgoczy L, Pesti M, Papp T, et al. In vitro synergistic interactions of the effects of various statins and azoles against some clinically important fungi. FEMS microbiology letters. 2010; 307(2):175-84. doi: 10.1111/j.1574-6968.2010.01972.x PubMed PMID: PMID: 20636975.
43. Flemming HC, Wingender J. The biofilm matrix. Nature reviews Microbiology. 2010; 8(9):623-33. doi: 10.1038/nrmicro2415 PubMed PMID: PMID: 20676145.
44. Renner LD, Weibel DB. Physicochemical regulation of biofilm formation. MRS bulletin/Materials Research Society. 2011; 36(5):347-55. doi: 10.1557/mrs.2011.65 PubMed PMID: PMID: 22125358; PubMed Central PMCID: PMC3224470.
45. Abdallah M, Benoliel C, Drider D, Dhulster P, Chihib NE. Biofilm formation and persistence on abiotic surfaces in the context of food and medical environments. Archives of microbiology. 2014; 196(7):453-72. doi: 10.1007/s00203-014-0983-1 PubMed PMID: PMID: 24744186.
46. Mah TF. Biofilm-specific antibiotic resistance. Future microbiology. 2012; 7(9):1061-72. doi: 10.2217/fmb.12.76 PubMed PMID: PMID: 22953707.
47. Ganeshnarayan K, Shah SM, Libera MR, Santostefano A, Kaplan JB. Poly-N-acetylglucosamine matrix polysaccharide impedes fluid convection and transport of the cationic surfactant cetylpyridinium chloride through bacterial biofilms. Applied and environmental microbiology. 2009; 75(5):1308-14. doi: 10.1128/AEM.01900-08 PubMed PMID: PMID: 19114520; PubMed Central PMCID: PMC2648167.
48. Busuioc M, Mackiewicz K, Buttaro BA, Piggot PJ. Role of intracellular polysaccharide in persistence of Streptococcus mutans. Journal of bacteriology. 2009; 191(23):7315-22. doi: 10.1128/JB.00425-09 PubMed PMID: PMID: 19801415; PubMed Central PMCID: PMC2786568.
49. Fischbach MA, Walsh CT. Antibiotics for emerging pathogens. Science. 2009; 325(5944):1089-93. doi: 10.1126/science.1176667 PubMed PMID: PMID: 19713519; PubMed Central PMCID: PMC2802854.